SCHEMBL6169083

SCHEMBL6169083

CCOC(=O)c1ccc(N(Cc2ccccc2Cl)C(C)=O)c([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 6/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
LMNA P02545 1/20 0.45
PTGER4 P35408 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
THRB P10828 2/20 0.42
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HCAR3 P49019 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170389 0.92 KMT2A (0.48) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6170317 0.89 KMT2A (0.50) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6167784 0.82 KMT2A (0.47) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6170395 0.82 KMT2A (0.48) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6170467 0.81 KMT2A (0.52) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6170305 0.81 KMT2A (0.46) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6170369 0.81 KMT2A (0.47) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6171240 0.79 ALDH1A1 (0.48) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6169314 0.78 KMT2A (0.45) MAPTKMT2AALDH1A1POLBKDM4E
SCHEMBL6168155 0.78 KMT2A (0.44) MAPTKMT2AALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed